Low Dose Radiotherapy for Osteoarthritis
Recruiting · NCT07715188 · Interventional (participants receive a specific treatment) · Lead sponsor: Abramson Cancer Center at Penn Medicine
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This single institution, multi-site, single arm prospective study will enroll patients with a history of OA and assess changes in pain and function after treatment with LDRT as measured by patient-reported outcomes.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- 18 years or older
- Diagnosis of OA \>3 months in hips, knees, hands, shoulders, ankles or elbows.
- Refractory to standard of care therapies for OA or those who are being considered for more aggressive interventional treatment such as joint replacement, but more conservative treatment is desired.
- Provision of signed and dated informed consent.
Exclusion criteria
- Unable to reasonably complete study instruments.
Where it is running
2 locations listed across 1 US state.
- Penn Presbyterian Medical Center - Philadelphia, Pennsylvania, United States
- Perelman Center for Advanced Medicine - Philadelphia, Pennsylvania, United States